Clinical Trial Update: Optimization of Cyclosporin in Atopic Dermatitis Through Multiomic Predictive Models of Treatment Response [Phase 4]

View source ↗

Summary

Phase 4 trial exploring optimization of cyclosporin in atopic dermatitis using multiomic predictive models to predict treatment response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Cyclosporin (cyclosporine)

Snippet

Sponsor: Instituto de Investigación Hospital Universitario La Paz | Conditions: Atopic Dermatitis | Phase 4 | Status: UNKNOWN